It's CES week, which means the official unveiling of new and sometimes out-there tech products designed to help us live ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects Marla Broadfoot, Knowable Magazine Some people are genetically built to require less sleep than the ...

The first medication for obstructive sleep apnea has been approved by the US ... to consult with a doctor before taking Zepbound and to monitor for any complications. Sleep expert Dr.

A baby sleep consultant from the U.K. has offered a timely reminder to new moms and dads that the challenging early years of parenting do get easier. Cher Fletcher, 42, posted a public service ...

The FDA has approved Zepbound (tirzepatide) for treating moderate to severe obstructive sleep apnea (OSA ... Health care providers are advised to monitor patients with kidney disease, diabetic ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Instead of getting the recommended eight hours of sleep every night, most people have been averaging six or seven hours per night; sometimes, it's even less. While one or two hours less may not ...

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans. "This is a major step ...

The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.